Search results
Screening recommendations should be adapted based on anatomy, (i.e., annual, routine screening for chlamydia in cisgender women < 25 years old should be extended to all transgender men and gender diverse people with a cervix.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that all sexually active women 24 years or younger and women 25 years or older at increased risk for infection be screened for chlamydia (B recommendation) and gonorrhea (B recommendation) and concludes that current evidence is insufficient to assess the ...
- Amy Cantor, Tracy Dana, Jessica C. Griffin, Heidi D. Nelson, Chandler Weeks, Kevin L. Winthrop, Roge...
- 2021
Jul 23, 2021 · For transgender persons with HIV infection who have sex with cisgender men and transgender women, STI screening should be conducted at least annually, including syphilis serology, HCV testing, and urogenital and extragenital NAAT for gonorrhea and chlamydia.
- Kimberly A Workowski, Laura H Bachmann, Philip A Chan, Christine M Johnston, Christina A Muzny, Ina ...
- 2021
- Follow-Up
- Management of Sex Partners
- Special Considerations
Test of cure to detect therapeutic failure (i.e., repeat testing 4 weeks after completing therapy) is not advised for nonpregnant persons treated with the recommended or alternative regimens, unless therapeutic adherence is in question, symptoms persist, or reinfection is suspected. Moreover, using chlamydial NAATs at <4 weeks after completion of t...
Sex partners should be referred for evaluation, testing, and presumptive treatment if they had sexual contact with the partner during the 60 days preceding the patient’s onset of symptoms or chlamydia diagnosis. Although the exposure intervals defining identification of sex partners at risk are based on limited data, the most recent sex partner sho...
Pregnancy
Clinical experience and published studies indicate that azithromycin is safe and effective during pregnancy (824–826). Doxycycline is contraindicated during the second and third trimesters of pregnancy because of risk for tooth discoloration. Human data reveal that levofloxacin presents a low risk to the fetus during pregnancy but has potential for toxicity during breastfeeding; however, data from animal studies increase concerns regarding cartilage damage to neonates (431). Test of cure (i.e...
The Task Force recommends screening for these infections in sexually active women and pregnant people 24 years and younger, or 25 years and older if at increased risk. There is not enough evidence to recommend for or against screening for these infections in men.
Oct 28, 2021 · Screening recommendations for cisgender women regarding gonorrhea, chlamydia, and cervical cancer should be extended to all transgender men and gender-diverse people with a cervix. Screening at the pharyngeal and rectal sites for gonorrhea and chlamydia should be considered based on reported sexual behaviors and exposure.
Apr 1, 2015 · The USPSTF recommends screening for chlamydia in sexually active women aged 24 years or younger and in older women who are at increased risk for infection.
